Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxytocin for Social Stress in Alcohol Use Disorder
NCT03610633Phase 2Completed
- Sponsor
- Medical University of South Carolina
- Start
- Mar 2016
- Primary completion
- Sep 2018
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in alcohol use disorder (AUD) comparing Oxytocin with Placebo (2 arms). Primary endpoint: Corticolimbic Functional Connectivity Based on fMRI Blood Oxygenation Level Dependent (BOLD) Response. Started Mar 2016; status: completed.
02
Drugs
oxytocin
03
Conditions
alcohol use disorder (AUD)
Beyond the preview
Go deeper on NCT03610633.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03610633.